in fact be minor, are often exploited by Counsel for one side or the other in open Court. It may be good fun, but it can be a traumatic experience for one, or maybe both, doctors.
Also, if solicitors were obliged to disclose all the information which they have obtained at an early stage, rather than doing so under threat of a Court Orderor even at the Hearingdifferences of opinion between medical witnesses would occur less often.
It is important to remember that we are not concerned either with liability or with the assessment of compensation. Therefore, the doctor is able to accept instruction on behalf of either the-plaintiff or the defendant and either is entitled to instruct the doctor ofhis choice. Judgement on this point was given in the Court ofAppeal in the case ofJeremiah Murphy-v-Ford Motor Company Limited, 9th October 1970.
The plaintiff is almost certain to arrive for examination under the impression that you are either 'for' or 'against' him because he will know whether his solicitors or those acting for the defendant have instructed you. It is essential that he is persuaded from the beginning that you are concerned only with the medical facts and that these must include occupational, past medical and family histories. Occasionally the plaintiff has been advised not to answer questions on these aspects. In such cases I have found that it is appropriate to say that there is no point in continuing the consultationthat usually ensures that questions are answered.
Technical terms and ambiguous statements should be avoided in reports. The latter may well provide ammunition for opposing Counsel. I once referred in a report to 'early' nodulation on X-rays of a plaintiff claiming for pneumoconiosis. Opposing Counsel made much of that in cross-examination.
These are general points which apply in preparation of reports in relation to any claim at common law, be it asthma, alveolitis, pneumoconiosis, fracture, loss of limb or back injury.
As it is difficult to diagnose asthma and to establish beyond reasonable doubt that it is caused by an agent in the working environment, the problems which confront members of the legal profession, and judges in particular, when there is conflicting medical evidence are considerable.
Lawyers who deal regularly with claims relating to any form of lung disease have an almost child-like faith in the results of lung function tests. To them a few units below predicted normal in any one of a series of tests can be more important than any clinical or other evidence which may be presented.
In claims for pneumoconiosis, X-rays can be produced. Judges do not like having to view these and have minor differences explained to thembut there is at least some objective evidence of an abnormality. For asthma claims they are likely to be presented with several yards of paper on which peak flow has been recorded. This may be valuable evidence in many cases of work-related asthma but results depend to some extent on the plaintiff's breathing pattern and on the ability or will to perform the test to their best possible limit. A shallow breather may show little variation and a small dip in the pattern may be ignored. I venture to suggest that in patients who have asthma ofoccupational origin the clinical history is diagnostic in the majority of cases.
I have heard it said in Court that it is not possible to diagnose asthma on the basis ofhistory and clinical examination. I found that an astonishing statement and was reminded of a saying attributed to Lord Horder to the effect that if one listens to what the patient says you will be given the diagnosis in more than 90% of cases. That, however, does not absolve one from making a careful clinical examination followed by such further investigations as may confirm or refute the initial diagnosis. Although there has been much interest in occupational asthma and alveolitis in recent years, there remain a number of important unanswered questions about these conditions. The questions that I have chosen are those that I consider important, in terms of understanding and prevention. This is not to deny that there are also other issues of interest about the conditions. Who will be affected? Is it possible to predict which individual will develop occupational asthma or alveolitis from a particular exposure? Or to predict which individual will not? Clearly, it is widely believed to be possible because the screening of applicants to work with substances known to be capable of inducing sensitization and asthma, in particular, is now quite a common practice. The aims of screening can be to reduce the number of affected persons in the exposed population or to prevent especially susceptible individuals from putting themselves at risk. The two aims cannot usually be achieved with a single screening test. The following example illustrates some ofthe problems of screening in relation to occupational asthma. Table 1 shows data from a cross-sectional study of workers exposed to allergens from small laboratory animals' Atopic status was determined by skin pricktesting with common inhalant allergens and more than a third ofthe population was atopic on this basis. The proportion with any allergic symptoms related to the animals did not differ with atopic status. A higher proportion of atopics than non-atopics had asthma related to the animals, but nevertheless a third ofthose with asthma were non-atopic. In Table 2 , the relationship between a previous history of asthma and symptoms is shown. Again, the relationship was mainly with animal-related asthma. In this case, however, two thirds of those with animal-asthma had no previous history of asthma.
In considering the usefulness of screening tests, it is usual to calculate their sensitivity, specificity and positive predictive value. Table 3 illustrates the calculation ofthese variables. Sensitivity is the ability to correctly detect those who will develop the condition, specificity is the ability to detect those who will not develop the condition and positive predictive value is the ability to detect individuals themselves at high risk of developing the condition. Table 3 also shows the calculated values ofthese variables from the study of animal workers'. Neither atopy nor previous asthma gives satisfactory values for the prediction of animal-asthma; although a history ofprevious asthma was specific it still had a low positive predictive value. Use of these criteria for screening would thus fail to detect people who would develop animal-asthma and exclude many others unnecessarily. A recent review of various screening criteria for animal handlers in use by institutions in the USA concluded that the evidence for their efficacy was poor and that there was no justification for their routine use at present2. The same picture emerges for other exposures giving rise to occupational asthma; the use of screening seems unrelated to evidence of efficacy.
Predicting those who will develop occupational alveolitis is even more difficult. Interestingly, there is evidence of a negative association between smoking and the development of antibodies in, for example, farmer's lung3 and humidifier fever4. Clearly, no one would seriously suggest excluding non-smokers from work involving exposures that can precipitate alveolitis. Rather, the situation requires reduction of exposure levels, and this is also true in relation to occupational asthma.
Can monitoring of exposed populations help prevention? Are there ways of testing exposed populations to give 'early warning' of those becoming sensitized so that they can be removed from the exposure before they develop symptoms? I will give two examples to illustrate problems with 'sensitization' monitoring. Table 4 shows data from the study of animal workers mentioned above'. Nearly all those with animal-asthma had positive skin tests with antigens from the animals; there were a number of those with other animal allergic symptoms (mainly rhinitis) who were skin test negative to animal antigens; but, strikingly, very few of those exposed without symptoms were skin test positive to animal antigens. This latter finding from a cross-sectional study suggested that, if skin test conversion precedes symptoms, itdoesnotprecedethemby long. Otherwise, one would expect quite a few who were skin test positive but without symptoms (yet). This finding could be confirmed in a follow-up investigation but it suggests that monitoring of sensitization (with skin tests) in this population would not help to prevent symptoms developing. The role of sensitization monitoring in alveolitistype reactions is also uncertain. Several individuals from a population workingin an operatingtheatre with a contaminated humidifier (giving rise to humidifier fever in some of the workers) were challenged with a sample of water from the humidifier5: two who had circulating antibodies and had had attacks of humidifier fever;!two who had antibodies but no symptoms; two exposed workers who had neither antibodies nor symptoms; and two non-exposed controls. Both those with previous symptoms reacted to the challenge, one of those with antibodies but no previous symptoms reacted and one of those without antibodies or previous symptoms reacted. Neither of the controls reacted. The reaction in the-exposed individual without antibodies suggested that there could be local antibody involved but illustrated that monitoring for systemic antibody is insufficient to identify individuals at risk of developing symptoms in this alveolitis-type reaction.
Is there any risk to exposed workers without acute symptoms? In occupational asthma and alveolitis, interest has mainly been focused on those individuals who develop acute symptoms and the exposures have been assumed to be harmless to other exposed individuals. However, this may not be true. Specific IgG and IgE to rat urinary allergen were estimated in the sera6 of the population of workers exposed to small laboratory animals referred to previously'. Levels of specific IgE correlated well with positive skin reactions to animal antigens and with asthma related to the animals. Specific IgG was found in all the sera containing specific IgE. It was also found in the sera of 30% of the exposed, asymptomatic workers and seemed to be related to the estimated degree of exposure. The significance of this specific IgG in the asymptomatic individuals is unknown but it does indicate an immunological response to the exposure and it is probably premature to dismiss it as harmless without knowing more about what happens to individuals with IgG compared with those without. Such data is lacking at present. Thus, it is not possible to say with confidence that individuals without acute effects of an exposure are quite unharmed by the exposure; more information is needed.
What happens to exposed populations in the long-term? The prognosis for individuals who develop occupational asthma has recently been reviewed7. There is evidence that people who develop occupational asthma related to any of a number of substances continue to have symptoms and have persisting bronchial hyperreactivity after leaving the exposure. It seems that persistence of symptoms is more likely with a longer duration of symptoms before diagnosis, poorer lung function and more severe non-specific bronchial hyperreactivity at the time of diagnosis7. While this suggests that rapid diagnosis and removal from exposure are important, economic factors may make workers unwilling to declare symptoms or even persist in the exposure after diagnosis, using suppressive medication or personal protection (such as air-stream helmets). Suppressive medication, such as sodium cromoglycate or inhaled steroids, can sometimes reduce symptoms but may not prevent continuing bronchial damage from the exposure; removal from exposure is certainly a safer option.
Very little is known about long-term,effects of exposures capable of inducing occupational asthma on those workers who do not develop apparent acute effects. The scanty information that is available is not reassuring. Studies of grain workers in Canada have indicated a long-term loss of lung function8.
This was found even among non-smoking grain workers9. This may be related to the finding, in a small study of dock workers in the United Kingdom, of an across-shift fall in ventilatory capacity when working with barley cargoes even in those without any symptoms related to the-exposure'0. Follow-up studies of workers exposed to isocyanates (excluding those who develop asthma and leave) have suggested a small excess loss of ventilatory capacity related to the exposure, particularly among non-smokers" (also, Mrs M McDermott, personal communication).
How can strategies for prevention be developed? I have indicated that pre-employment screening and monitoring exposed populations for evidence of sensitization preceding symptoms are unlikely to be effective in preventing the appearance of occupational asthma and alveolitis in populations exposed to particular substances. And they do not address the question of possible effects in other exposed workers. Satisfactory answers to the questions I have posed will only come from careful follow-up studies of exposed populations, incorporating measurements of the allergens to which the workers are exposed. Such studies would allow an estimate ofthe true incidence of symptoms and sensitization (the values from crosssectional studies are likely to be under-estimates) and of the long term effects in the whole exposed population. They would also be a framework for the introduction of control measures, especially reduction of exposure, and for checking their effectiveness in terms ofmeasured allergen and incidence ofsymptoms.
Follow-up studies are expensive andtime-consuming, becoming increasingly difficult to undertake, yet reliable answers necessary for prevention ofill-effects from exposures causing occupational asthma and alveolitis will be very difficult to obtain without such studies. The alternative is to carry on with a mixture of pre-employment screening, of questionable value, and ad hoc measures to reduce exposure.
